Jeannie Baumann is a senior reporter for Bloomberg Law where she’s covered medical research policy and the life sciences industry since 2005. Since January 2020, she has primarily reported on COVID-19, particularly on vaccines and therapeutics. Baumann covers Capitol Hill and the federal agencies that relate to medical research, specifically NIH and the FDA. Her non-COVID coverage focuses on major NIH initiatives, health research funding, public health, research integrity and oversight, and new emerging medical technologies.
